Q1 2023 13F Holders as of 31 Mar 2023
-
Type / Class
-
Equity / Voting Common Shares, no par value
-
Shares outstanding
-
51,654,406
-
Number of holders
-
22
-
Total 13F shares, excl. options
-
2,565,385
-
Shares change
-
+41,212
-
Total reported value, excl. options
-
$3,924,875
-
Value change
-
+$61,558
-
Put/Call ratio
-
9.1%
-
Number of buys
-
8
-
Number of sells
-
8
-
Price
-
$1.53
Institutional Holders of DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) as of Q1 2023
As of 31 Mar 2023 DiaMedica Therapeutics Inc. - Voting Common Shares, no par value (DMAC) had 22 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions held a total of 2,565,385 shares of stock of the company.
Largest 10 holders included COOPERMAN LEON G, VANGUARD GROUP INC, JACOB ASSET MANAGEMENT OF NEW YORK LLC, GEODE CAPITAL MANAGEMENT, LLC, NORTHERN TRUST CORP, BlackRock Inc., STATE STREET CORP, RENAISSANCE TECHNOLOGIES LLC, MORGAN STANLEY, and CITADEL ADVISORS LLC.
This table shows 22 institutional shareholders of the security as of 31 Mar 2023.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.